Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Initial Vancomycin Taper for the Prevention of Recurrent Clostridium Difficile Infection

NCT04138706 is registered in ClinicalTrials.gov with McGill University Health Centre/Research Institute of the McGill University Health Centre as lead sponsor.

NCT NCT04138706
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04138706 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Initial Vancomycin Taper for the Prevention of Recurrent Clostridium Difficile Infection
Lead sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase
Phase 3
Overall status
Completed
Start date
November 19, 2020
Completion date
November 22, 2024
Enrollment
263 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium difficile infection